Dynamic cell cycle kinetics of normal CD34+ cells and CD38+/- subsets of haemopoietic progenitor cells in G-CSF-mobilized peripheral blood

被引:8
|
作者
Holm, M
Thomsen, M
Hoyer, M
Hokland, P
机构
[1] Aarhus Univ Hosp, Dept Med & Haematol, Aarhus, Denmark
[2] Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark
关键词
haemopoietic stem cells; cell cycle kinetics; S-phase duration; growth factor stimulation; CD38; subsets;
D O I
10.1046/j.1365-2141.1999.01468.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Using a recently developed flow cytometric assay for the simultaneous measurement of cell surface antigens, DNA content and bromodeoxyuridine incorporation we have for the first time determined the labelling index (LI), the duration of the S-phase (Ts) and the potential doubling time (Tpot) of purified CD34(+) cells mobilized by G-CSF from 10 normal donors. Although CD34(+) cells were not actively cycling immediately following purification, up to 5% could nevertheless traverse cell cycle without exogenous stimulation during the first 24 h of culture. In addition, it was possible to induce CD34+ cells to enter cycling by stimulation with haemopoietic growth factors (IL-3, IL-6 and SCF), resulting in median Tpot values of 18.2 d at 21 h, 7.7 d at 29 h, and 4.5 d at 3.7 h, Importantly, stimulation of CD34(+) cells was seen almost exclusively within the CD38(+) subset (mean Tpot value 2.8 d), whereas CD38(-) cells were not recruited into cycle (mean Tpot value 35.9 d). In conclusion, although cell cycle entry and progression can easily be induced in differentiated CD34(+)/CD38(+) cells, immature CD34(+)/CD38(-) cells will remain dormant in most of the clinical and laboratory stimulation protocols hitherto employed. This assay call be used to obtain detailed cell cycle kinetics in leucocyte subsets in health and disease.
引用
收藏
页码:1002 / 1013
页数:12
相关论文
共 50 条
  • [1] Cell kinetics of normal G-CSF mobilized CD38+ and CD38-subsets of CD34+ hematopoietic stem cells by multiparameter flow cytometry.
    Holm, M
    Hoyer, M
    Hokland, P
    BLOOD, 1998, 92 (10) : 60A - 60A
  • [2] T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cells
    D Rondelli
    C Anasetti
    A Fortuna
    M Ratta
    M Arpinati
    G Bandini
    RM Lemoli
    S Tura
    Bone Marrow Transplantation, 1998, 21 : 1183 - 1191
  • [3] T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cells
    Rondelli, D
    Anasetti, C
    Fortuna, A
    Ratta, M
    Arpinati, M
    Bandini, G
    Lemoli, RM
    Tura, S
    BONE MARROW TRANSPLANTATION, 1998, 21 (12) : 1183 - 1191
  • [4] Examination of the CD34+CD38- cell population in G-CSF-mobilized peripheral blood.
    Lagarias, DM
    Paglieroni, TG
    Richman, CM
    BLOOD, 1997, 90 (10) : 1643 - 1643
  • [5] Normal G-CSF-mobilized CD34+ peripheral blood stem cells in paroxysmal nocturnal hemoglobinia: a perspective for autologous transplantation
    P Musto
    G D’Arena
    N Cascavilla
    M Carotenuto
    Leukemia, 1997, 11 : 890 - 891
  • [6] Normal G-CSF-mobilized CD34+ peripheral blood stem cells in paroxysmal nocturnal hemoglobinuria: A perspective for autologous transplantation
    Musto, P
    DArena, G
    Cascavilla, N
    Carotenuto, M
    LEUKEMIA, 1997, 11 (06) : 890 - 892
  • [7] Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation
    Ojeda-Uribe, M
    Sovalat, H
    Bourderont, D
    Brunot, A
    Marr, A
    Lewandowski, H
    Chabouté, V
    Peter, P
    Henon, P
    CYTOTHERAPY, 2004, 6 (06) : 571 - 583
  • [8] Autologous G-CSF-Mobilized Peripheral Blood CD34+ Cell Therapy for Diabetic Patients With Chronic Nonhealing Ulcer
    Tanaka, Rica
    Masuda, Haruchika
    Kato, Shunichi
    Imagawa, Kotaro
    Kanabuchi, Kazuo
    Nakashioya, Chie
    Yoshiba, Fumiaki
    Fukui, Tsuyoshi
    Ito, Rie
    Kobori, Michiru
    Wada, Mika
    Asahara, Takayuki
    Miyasaka, Muneo
    CELL TRANSPLANTATION, 2014, 23 (02) : 167 - 179
  • [9] Quantitation of CD34+DR+/CD34+DR+ cells before and after immunoselection of CD34+ cells from G-CSF mobilized peripheral blood progenitor cells(PBPC).
    Martinez, C
    UrbanoIspizua, A
    Rozman, C
    Mann, P
    Mazzara, R
    Carreras, E
    Rovira, M
    Sierra, J
    Briones, J
    Montserrat, E
    BLOOD, 1996, 88 (10) : 3719 - 3719
  • [10] AMD3100-mobilized CD34+ cells are phenotypically different and better targets for retroviral transduction than G-CSF-mobilized CD34+ cells in rhesus macaques
    Larochelle, A
    Krouse, A
    Orlic, D
    Donahue, RE
    Dunbar, CE
    Hematti, P
    MOLECULAR THERAPY, 2004, 9 : S268 - S268